Skip to main content
. 2010 Sep 20;13(9):882–891. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2010.09.09

4.

纳入的非小细胞肺癌KRAS突变研究

Eligible studies for KRAS mutation of NSCLC

KRAS mutation Pairs Primary NSCLC Metastases Inconsistency
n Percent n Percent n Percent
Badalian G[28] 11 3 27.27% 3 27.27% 4 36.36%
Cortot AB[18] 21 3 14.29% 4 19.05% 6 28.57%
Kalikaki A[19] 25 5 20.00% 5 20.00% 6 24.00%
Schmid K[22] 96 28 29.17% 20 20.83% 25 26.04%
Monaco SE[25] 40 11 27.50% 4 10.00% 9 22.50%
Sum 193 50 25.91% 36 18.65% 50 25.91%